Today, Matt Schettenhelm, Bloomberg Intelligence Senior Litigation Analyst, breaks down a California's jury's rejection of Elon Musk's claim that Sam Altman betrayed OpenAI's original mission when it became a for-profit business, finding that Musk waited too long to sue his former company. Then, Dr. Doug Lucas, an orthopedic surgeon who leads the clinical side for bone health and longevity science at LifeMD, joins the show live from the New York Stock Exchange to talk bone health and preventing